|
Originally published In Press as doi:10.1074/jbc.M003039200 on June 6, 2000
J. Biol. Chem., Vol. 275, Issue 37, 29031-29041, September 15, 2000
Distant Enhancers Stimulate the Albumin Promoter through Complex
Proximal Binding Sites*
William R.
Vorachek §,
Claire M.
Steppan ¶,
Michele
Lima ,
Heather
Black ,
Raka
Bhattacharya **,
Ping
Wen  ,
Yasuo
Kajiyama , and
Joseph
Locker §§
From the Department of Pathology, University of
Pittsburgh, Pittsburgh, Pennsylvania 15261 and the
Department of Pathology, Albert Einstein College of Medicine,
Bronx, New York 10461
The albumin- -fetoprotein locus
epitomizes the main features of transcriptional regulation of fetal and
adult hepatocyte-specific genes: developmentally regulated promoters
and strong distant enhancers. Full enhancer activity required only a
proximal albumin-promoter region containing the TATA box, hepatic
nuclear factor 1 (HNF1), and nuclear factor Y (NF-Y) sites.
Deletion of the HNF1 site abrogated enhancer and promoter activity,
whereas methylation of the site reduced all activity by about 3-fold.
Deletion of the NF-Y site attenuated activity by about half, but much
of the activity could be replaced by juxtaposition of an upstream
region (designated distal element IV). Gel shift and competition
analysis demonstrated that binding of architectural factors overlapped
NF-Y binding. Moreover, a mutation that eliminated NF-Y binding but
only minimally perturbed the surrounding region did not affect enhancer
function. In plasmids with a second promoter, the enhancers
simultaneously stimulated both albumin and -fetoprotein promoters
with minimal competition, but surprisingly some mutations in the
albumin promoter attenuated expression from both promoters, whereas
another uncoupled their expression. With single promoters, the function
of the proximal promoter region was controlled by three parameters in
the following hierarchy: HNF1 binding > local architecture > NF-Y binding, but integrated two-promoter function had a much
greater dependence on NF-Y.
*
This work was supported by National Institutes of Health
Grants CA68440 and CA76354 and American Cancer Society Grant NP-955.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Dept. of Environmental and Molecular Toxicology,
Oregon State University, Corvallis, OR 97331.
¶
Present address: Pfizer-Central Research, Box 943, Eastern
Point Road, Groton, CT 06320.
**
Present address: James A. Haley Research Center-151, 13000 Bruce.
B. Downs Blvd., Tampa, FL 33612.

Present address: University Hospitals of Cleveland, Dept. of
Pathology, 11000 Euclid Ave., Cleveland, OH 44106.
§§
To whom correspondence should be addressed: Albert Einstein
College of Medicine, School of Medicine, Dept. of Pathology, Bronx, NY
10461. Tel.: 718-430-3422; Fax: 718-430-3483; E-mail:
locker@aecom. yu.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Kajiyama, J. Tian, and J. Locker
Characterization of Distant Enhancers and Promoters in the Albumin-{alpha}-Fetoprotein Locus during Active and Silenced Expression
J. Biol. Chem.,
October 6, 2006;
281(40):
30122 - 30131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hiroki, Y.-H. Song, S. A. Liebhaber, and N. E. Cooke
The human vitamin D-binding protein gene contains locus control determinants sufficient for autonomous activation in hepatic chromatin.
Nucleic Acids Res.,
January 1, 2006;
34(8):
2154 - 2165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kajiyama, J. Tian, and J. Locker
Regulation of {alpha}-Fetoprotein Expression by Nkx2.8
Mol. Cell. Biol.,
September 1, 2002;
22(17):
6122 - 6130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Locker, D. Ghosh, P.-V. Luc, and J. Zheng
Definition and prediction of the full range of transcription factor binding sites--the hepatocyte nuclear factor 1 dimeric site
Nucleic Acids Res.,
September 1, 2002;
30(17):
3809 - 3817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Miccadei, R. De Leo, E. Zammarchi, P. G. Natali, and D. Civitareale
The Synergistic Activity of Thyroid Transcription Factor 1 and Pax 8 Relies on the Promoter/Enhancer Interplay
Mol. Endocrinol.,
April 1, 2002;
16(4):
837 - 846.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|